Biotest
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 9/9/2023
Pipeline by Phase
Therapeutic Focus
Clinical Trials (14)
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Started: 9/9/2023
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency
Started: 3/1/2013
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
Started: 12/22/2022
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
Started: 11/17/2021
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Started: 10/4/2016
This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)
Started: 11/1/2016
A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant
Started: 12/1/2012
Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19
Started: 10/6/2020
Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus
Started: 9/28/2015
Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis
Started: 10/1/2013
Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP
Started: 8/1/2011
Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)
Started: 12/1/2010
Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis
Started: 2/1/2010